HEPATITIS B， CHRONIC
Clinical trials for HEPATITIS B， CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B， CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B， CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to cure chronic hepatitis b – early trial underway
Disease control OngoingThis study tests a new drug called AHB-137 in 86 adults with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if AHB-137 can clear the hepatitis B surface antigen from the blood, which would mean the virus is under control and patients might be …
Matched conditions: HEPATITIS B， CHRONIC
Phase: PHASE2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for hepatitis b: Real-World trial of pradefovir underway
Disease control OngoingThis study is testing a drug called pradefovir mesylate in 400 adults with chronic hepatitis B. The goal is to see how well it lowers the virus and how safe it is in everyday medical practice, not just in a strict research setting. Participants are being followed for up to 65 wee…
Matched conditions: HEPATITIS B， CHRONIC
Sponsor: Juan Li • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Hepatitis b patients may be able to ditch daily pills, new trial hopes
Disease control OngoingThis study tests whether adults with chronic hepatitis B who have no liver scarring can safely stop taking antiviral drugs. The 140 participants have undetectable virus levels and negative HBeAg status. Researchers will monitor for viral relapse and liver problems over time.
Matched conditions: HEPATITIS B， CHRONIC
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Blood test boosts liver cancer detection in High-Risk patients
Diagnosis ENROLLING_BY_INVITATIONThis study is testing whether adding a blood test called the GAAD score to regular ultrasound scans can improve the detection of liver cancer in people at high risk, such as those with cirrhosis or chronic hepatitis. About 2,100 participants will get both tests every six months f…
Matched conditions: HEPATITIS B， CHRONIC
Phase: NA • Sponsor: Siriraj Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
10-Year hepatitis study aims to unlock secrets of liver disease
Knowledge-focused OngoingThis study follows people with chronic hepatitis B or C for up to 10 years to track how the disease changes over time. A smaller group with hepatitis B will receive the drug tenofovir alafenamide for 2 years to see if it reduces liver stiffness. Participants provide blood samples…
Matched conditions: HEPATITIS B， CHRONIC
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC